This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and
...
health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publications are available that provide a background to pharmacovigilance and, as far as possible, that material will not be repeated here. Health officials, planners, the staff of Pharmacovigilance Centres, public health teams and all health workers should become familiar with these publications, which are: • Safety of Medicines: A guide to detecting and reporting adverse drug reactions
more
The Lay Counselor Cadre in Botswana
District Level M & E Training and Reference Material for Primary Health Care Programmes
Harm Reduction Journal (2016) 13:28
DOI 10.1186/s12954-016-0118-x
54th directing council; 67th session of the regional Committee of WHO for the Americas
CD54/11, Rev. 1, 2 October 2015, Original: Spanish
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of
...
Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of infections. Clofazimine resistance is still rare but this antimicrobial cannot be given alone
more
Reflections from disability research using the ICF in Afghanistan and Cambodia | Working Paper Series: No. 11
Disability Inclusion | Published by Child Development & Rights and Sustainable Health on behalf of World Vision International.